 | • レポートコード：QYR9ST03940 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、リソソーム蓄積症の世界市場について調査・分析し、リソソーム蓄積症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（酵素補充療法、基質減少療法、シスチン枯渇剤）、用途別（病院、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のリソソーム蓄積症市場動向 ・主要企業別マーケットシェア ・リソソーム蓄積症の種類別市場規模2014-2019 （酵素補充療法、基質減少療法、シスチン枯渇剤） ・リソソーム蓄積症の用途別市場規模2014-2019 （病院、外来手術センター） ・リソソーム蓄積症の北米市場：主要企業・種類別/用途別市場規模 ・リソソーム蓄積症のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・リソソーム蓄積症の中国市場：主要企業・種類別/用途別市場規模 ・リソソーム蓄積症の日本国内市場：主要企業・種類別/用途別市場規模 ・リソソーム蓄積症の東南アジア市場：主要企業・種類別/用途別市場規模 ・リソソーム蓄積症のインド市場：主要企業・種類別/用途別市場規模 ・リソソーム蓄積症の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Actelion Pharmaceuticals、BioMarin、Genzyme、Shire、Alexion Pharmaceuticals、Amicus Therapeutics、Chiesi Farmaceutici、Greenovation Biotech And FGK Clinical Research、Horizon Pharma、Leadiant Biosciences、Mylan） ・リソソーム蓄積症の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.According to the report, one driver in the market is unmet medical needs.
In 2018, the global Lysosomal Storage Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Lysosomal Storage Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Storage Diseases development in United States, Europe and China.
The key players covered in this study
Actelion Pharmaceuticals
BioMarin
Genzyme
Shire
Alexion Pharmaceuticals
Amicus Therapeutics
Chiesi Farmaceutici
Greenovation Biotech And FGK Clinical Research
Horizon Pharma
Leadiant Biosciences
Mylan
Market segment by Type, the product can be split into
Enzyme Replacement Therapy
Substrate Reduction Therapy
Cystine Depleting Agents
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Lysosomal Storage Diseases status, future forecast, growth opportunity, key market and key players.
To present the Lysosomal Storage Diseases development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Lysosomal Storage Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type (2014-2025)
1.4.2 Enzyme Replacement Therapy
1.4.3 Substrate Reduction Therapy
1.4.4 Cystine Depleting Agents
1.5 Market by Application
1.5.1 Global Lysosomal Storage Diseases Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Lysosomal Storage Diseases Market Size
2.2 Lysosomal Storage Diseases Growth Trends by Regions
2.2.1 Lysosomal Storage Diseases Market Size by Regions (2014-2025)
2.2.2 Lysosomal Storage Diseases Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Lysosomal Storage Diseases Market Size by Manufacturers
3.1.1 Global Lysosomal Storage Diseases Revenue by Manufacturers (2014-2019)
3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Lysosomal Storage Diseases Key Players Head office and Area Served
3.3 Key Players Lysosomal Storage Diseases Product/Solution/Service
3.4 Date of Enter into Lysosomal Storage Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Lysosomal Storage Diseases Market Size by Type (2014-2019)
4.2 Global Lysosomal Storage Diseases Market Size by Application (2014-2019)
5 United States
5.1 United States Lysosomal Storage Diseases Market Size (2014-2019)
5.2 Lysosomal Storage Diseases Key Players in United States
5.3 United States Lysosomal Storage Diseases Market Size by Type
5.4 United States Lysosomal Storage Diseases Market Size by Application
6 Europe
6.1 Europe Lysosomal Storage Diseases Market Size (2014-2019)
6.2 Lysosomal Storage Diseases Key Players in Europe
6.3 Europe Lysosomal Storage Diseases Market Size by Type
6.4 Europe Lysosomal Storage Diseases Market Size by Application
7 China
7.1 China Lysosomal Storage Diseases Market Size (2014-2019)
7.2 Lysosomal Storage Diseases Key Players in China
7.3 China Lysosomal Storage Diseases Market Size by Type
7.4 China Lysosomal Storage Diseases Market Size by Application
8 Japan
8.1 Japan Lysosomal Storage Diseases Market Size (2014-2019)
8.2 Lysosomal Storage Diseases Key Players in Japan
8.3 Japan Lysosomal Storage Diseases Market Size by Type
8.4 Japan Lysosomal Storage Diseases Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Lysosomal Storage Diseases Market Size (2014-2019)
9.2 Lysosomal Storage Diseases Key Players in Southeast Asia
9.3 Southeast Asia Lysosomal Storage Diseases Market Size by Type
9.4 Southeast Asia Lysosomal Storage Diseases Market Size by Application
10 India
10.1 India Lysosomal Storage Diseases Market Size (2014-2019)
10.2 Lysosomal Storage Diseases Key Players in India
10.3 India Lysosomal Storage Diseases Market Size by Type
10.4 India Lysosomal Storage Diseases Market Size by Application
11 Central & South America
11.1 Central & South America Lysosomal Storage Diseases Market Size (2014-2019)
11.2 Lysosomal Storage Diseases Key Players in Central & South America
11.3 Central & South America Lysosomal Storage Diseases Market Size by Type
11.4 Central & South America Lysosomal Storage Diseases Market Size by Application
12 International Players Profiles
12.1 Actelion Pharmaceuticals
12.1.1 Actelion Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lysosomal Storage Diseases Introduction
12.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.1.5 Actelion Pharmaceuticals Recent Development
12.2 BioMarin
12.2.1 BioMarin Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lysosomal Storage Diseases Introduction
12.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.2.5 BioMarin Recent Development
12.3 Genzyme
12.3.1 Genzyme Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lysosomal Storage Diseases Introduction
12.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.3.5 Genzyme Recent Development
12.4 Shire
12.4.1 Shire Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lysosomal Storage Diseases Introduction
12.4.4 Shire Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.4.5 Shire Recent Development
12.5 Alexion Pharmaceuticals
12.5.1 Alexion Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lysosomal Storage Diseases Introduction
12.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.5.5 Alexion Pharmaceuticals Recent Development
12.6 Amicus Therapeutics
12.6.1 Amicus Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lysosomal Storage Diseases Introduction
12.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.6.5 Amicus Therapeutics Recent Development
12.7 Chiesi Farmaceutici
12.7.1 Chiesi Farmaceutici Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lysosomal Storage Diseases Introduction
12.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.7.5 Chiesi Farmaceutici Recent Development
12.8 Greenovation Biotech And FGK Clinical Research
12.8.1 Greenovation Biotech And FGK Clinical Research Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lysosomal Storage Diseases Introduction
12.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.8.5 Greenovation Biotech And FGK Clinical Research Recent Development
12.9 Horizon Pharma
12.9.1 Horizon Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lysosomal Storage Diseases Introduction
12.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.9.5 Horizon Pharma Recent Development
12.10 Leadiant Biosciences
12.10.1 Leadiant Biosciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lysosomal Storage Diseases Introduction
12.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2014-2019)
12.10.5 Leadiant Biosciences Recent Development
12.11 Mylan
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Lysosomal Storage Diseases Key Market Segments
Table Key Players Lysosomal Storage Diseases Covered
Table Global Lysosomal Storage Diseases Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lysosomal Storage Diseases Market Size Market Share by Type 2014-2025
Figure Enzyme Replacement Therapy Figures
Table Key Players of Enzyme Replacement Therapy
Figure Substrate Reduction Therapy Figures
Table Key Players of Substrate Reduction Therapy
Figure Cystine Depleting Agents Figures
Table Key Players of Cystine Depleting Agents
Table Global Lysosomal Storage Diseases Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Lysosomal Storage Diseases Report Years Considered
Table Global Lysosomal Storage Diseases Market Size 2014-2025 (Million US$)
Figure Global Lysosomal Storage Diseases Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lysosomal Storage Diseases Market Size by Regions 2014-2025 (Million US$)
Table Global Lysosomal Storage Diseases Market Size by Regions 2014-2019 (Million US$)
Table Global Lysosomal Storage Diseases Market Share by Regions 2014-2019
Figure Global Lysosomal Storage Diseases Market Share by Regions 2014-2019
Figure Global Lysosomal Storage Diseases Market Share by Regions 2019
Table Market Top Trends
Table Global Lysosomal Storage Diseases Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lysosomal Storage Diseases Market Share by Manufacturers (2014-2019)
Figure Global Lysosomal Storage Diseases Market Share by Manufacturers in 2018
Table Global Lysosomal Storage Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lysosomal Storage Diseases Product/Solution/Service
Table Date of Enter into Lysosomal Storage Diseases Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)
Table Global Lysosomal Storage Diseases Market Size Share by Type (2014-2019)
Figure Global Lysosomal Storage Diseases Market Size Market Share by Type (2014-2019)
Table Global Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table Global Lysosomal Storage Diseases Market Size Share by Application (2014-2019)
Figure Global Lysosomal Storage Diseases Market Size Market Share by Application (2014-2019)
Figure Global Lysosomal Storage Diseases Revenue Market Share by Application in 2018
Figure United States Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)
Table United States Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)
Table United States Key Players Lysosomal Storage Diseases Market Share (2018-2019)
Table United States Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)
Table United States Lysosomal Storage Diseases Market Share by Type (2014-2019)
Table United States Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table United States Lysosomal Storage Diseases Market Share by Application (2014-2019)
Figure Europe Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)
Table Europe Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)
Table Europe Key Players Lysosomal Storage Diseases Market Share (2018-2019)
Table Europe Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)
Table Europe Lysosomal Storage Diseases Market Share by Type (2014-2019)
Table Europe Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table Europe Lysosomal Storage Diseases Market Share by Application (2014-2019)
Figure China Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)
Table China Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)
Table China Key Players Lysosomal Storage Diseases Market Share (2018-2019)
Table China Lysosomal Storage Diseases Market Size by Type (2014-20189) (Million US$)
Table China Lysosomal Storage Diseases Market Share by Type (2014-2019)
Table China Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table China Lysosomal Storage Diseases Market Share by Application (2014-2019)
Figure Japan Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)
Table Japan Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)
Table Japan Key Players Lysosomal Storage Diseases Market Share (2018-2019)
Table Japan Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)
Table Japan Lysosomal Storage Diseases Market Share by Type (2014-2019)
Table Japan Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table Japan Lysosomal Storage Diseases Market Share by Application (2014-2019)
Figure Southeast Asia Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Diseases Market Share (2018-2019)
Table Southeast Asia Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Storage Diseases Market Share by Type (2014-2019)
Table Southeast Asia Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Storage Diseases Market Share by Application (2014-2019)
Figure India Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)
Table India Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)
Table India Key Players Lysosomal Storage Diseases Market Share (2018-2019)
Table India Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)
Table India Lysosomal Storage Diseases Market Share by Type (2014-2019)
Table India Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table India Lysosomal Storage Diseases Market Share by Application (2014-2019)
Figure Central & South America Lysosomal Storage Diseases Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lysosomal Storage Diseases Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lysosomal Storage Diseases Market Share (2018-2019)
Table Central & South America Lysosomal Storage Diseases Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lysosomal Storage Diseases Market Share by Type (2014-2019)
Table Central & South America Lysosomal Storage Diseases Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lysosomal Storage Diseases Market Share by Application (2014-2019)
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019) (Million US$)
Figure Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Actelion Pharmaceuticals Recent Development
Table BioMarin Company Details
Table BioMarin Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table BioMarin Recent Development
Table Genzyme Company Details
Table Genzyme Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Genzyme Recent Development
Table Shire Company Details
Table Shire Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Shire Recent Development
Table Alexion Pharmaceuticals Company Details
Table Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Alexion Pharmaceuticals Recent Development
Table Amicus Therapeutics Company Details
Table Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Amicus Therapeutics Recent Development
Table Chiesi Farmaceutici Company Details
Table Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Chiesi Farmaceutici Recent Development
Table Greenovation Biotech And FGK Clinical Research Company Details
Table Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Greenovation Biotech And FGK Clinical Research Recent Development
Table Horizon Pharma Company Details
Table Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Horizon Pharma Recent Development
Table Leadiant Biosciences Company Details
Table Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2014-2019)(Million US$)
Figure Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2014-2019)
Table Leadiant Biosciences Recent Development
Table Mylan Company Details
Table Global Lysosomal Storage Diseases Market Size by Regions (Million US$) 2019-2025
Figure Global Lysosomal Storage Diseases Market Size Share by Regions (2019-2025)
Figure Global Lysosomal Storage Diseases Market Size Share by Regions in 2025
Figure United States Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)
Figure China Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)
Figure India Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lysosomal Storage Diseases Market Size Forecast (2019-2025)(Million USD)
Table Global Lysosomal Storage Diseases Market Size by Product (2019-2025) (Million US$)
Figure Global Lysosomal Storage Diseases Market Size by Product (2019-2025)
Figure Global Lysosomal Storage Diseases Market Size by Product in 2025
Table Global Lysosomal Storage Diseases Market Size by Application (2019-2025) (Million US$)
Figure Global Lysosomal Storage Diseases Market Size by Application (2019-2025)
Figure Global Lysosomal Storage Diseases Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…- ホルモン補充療法の世界市場：市場規模・現状・予測 Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Hormonal imbalance disorders, with an increase in the ger…
- 後天的孤児血液疾患治療薬の世界市場：市場規模・現状・予測 Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …
- エアロゾル療法の世界市場：市場規模・現状・予測 Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol…
- 孤立性肺疾患治療の世界市場：市場規模・現状・予測 Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists.Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are en…